Abbott Biotherapeutics Corp.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Abbott Biotherapeutics Corp..The latest application filed is for "method for treating psoriasis".
- Abbott Biotherapeutics Corp. - Redwood City CA
- Abbott Biotherapeutics Corporation - Redwood City CA
| Patent | Date |
|---|---|
| Method For Treating Psoriasis App 20130071388 - Ehrhardt; Rolf O. ; et al. | 2013-03-21 |
| Therapeutic use of anti-CS1 antibodies Grant 8,349,330 - Williams , et al. January 8, 2 | 2013-01-08 |
| Compositions Against Cancer Antigen Liv-1 And Uses Thereof App 20120328513 - Law; Debbie ; et al. | 2012-12-27 |
| Compositions against cancer antigen LIV-1 and uses thereof Grant 8,313,745 - Mack , et al. November 20, 2 | 2012-11-20 |
| Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis Grant 8,309,084 - Ramakrishnan , et al. November 13, 2 | 2012-11-13 |
| Immunoglobulin display vectors Grant 8,283,170 - DuBridge , et al. October 9, 2 | 2012-10-09 |
| Antibodies against cancer antigen TMEFF2 and uses thereof Grant 8,257,708 - Bhaskar , et al. September 4, 2 | 2012-09-04 |
| Mammalian cell-based immunoglobulin display libraries Grant 8,163,546 - Akamatsu , et al. April 24, 2 | 2012-04-24 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120070440 - Williams; Marna ; et al. | 2012-03-22 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064083 - Williams; Marna ; et al. | 2012-03-15 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064068 - Williams; Marna ; et al. | 2012-03-15 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064069 - WILLIAMS; Marna ; et al. | 2012-03-15 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064067 - Williams; Marna ; et al. | 2012-03-15 |
| Therapeutic use of anti-CS1 antibodies Grant 8,133,981 - Williams , et al. March 13, 2 | 2012-03-13 |
| Therapeutic use of anti-CS1 antibodies Grant 8,088,898 - Williams , et al. January 3, 2 | 2012-01-03 |
| Stable Liquid Pharmaceutical Formulation Of IgG Antibodies App 20110318343 - KAISHEVA; Elizabet A. ; et al. | 2011-12-29 |
| Chimeric And Humanized Antibodies To Alpha5beta1 Integrin That Modulate Angiogenesis App 20110300133 - RAMAKRISHNAN; Vanitha ; et al. | 2011-12-08 |
| Immunoglobulin Display Vectors App 20110250611 - DuBridge; Robert ; et al. | 2011-10-13 |
| Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis Grant 8,017,116 - Ramakrishnan , et al. September 13, 2 | 2011-09-13 |
| Therapeutic use of anti-CS1 antibodies Grant 8,008,450 - Williams , et al. August 30, 2 | 2011-08-30 |
| Anti-her2 Antibodies And Their Uses App 20110177095 - Harding; Fiona A. ; et al. | 2011-07-21 |
| Immunoglobulin display vectors Grant 7,947,495 - DuBridge , et al. May 24, 2 | 2011-05-24 |
| Treatment of inflammatory bowel diseases with anti-IP-10 antibodies Grant 7,935,793 - Balasa , et al. May 3, 2 | 2011-05-03 |
| Stable Liquid Pharmaceutical Formulation Of Igg Antibodies App 20110070231 - Kaisheva; Elizabet A. ; et al. | 2011-03-24 |
| Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis Grant 7,897,148 - Ramakrishnan , et al. March 1, 2 | 2011-03-01 |
| NCAGE Code | 6JVK4 | ABBOTT BIOTHERAPEUTICS CORP. |
| CAGE Code | 6JVK4 | ABBOTT BIOTHERAPEUTICS CORP. |
| SEC | 0001441848 | ABBOTT BIOTHERAPEUTICS CORP of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 